1-GOLD-24-Home-Banner-Template-1584-x-396.jpg
  • LinkedIn
  • Black YouTube Icon

NEW ISSUE OF GOLD 

OUT NOW! 

Check out the new issue of GOLD! From the lessons pharma can learn from the tech giants to the sector’s work to reduce, refine and replace animal testing, the latest issue of GOLD considers the most pressing issues, trends and triumphs facing the industry today.

 

Catalyst of pharma 

Reshema Kemps-Polanco

Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology, talks to GOLD about her drive to succeed, her passion for diversity and creating healthy habits. 

Reshema-Kemps-Polanco-Novartis-Oncology.jpg

Cover feature

Following in the footsteps of tech giants

Following-in-the-footsteps-of-tech-giants.jpg

GOLD explores what techniques pharma companies can adopt and adapt from the tech giants dominating the stage of modern-day innovation. 

 
 

Editor's Picks

Opinion

Embracing pharma’s digital transformation  
Davidek-Herron-Roche.jpg

In his first regular column for GOLD, Davidek Herron discusses digital transformation in pharma, and how the industry can pursue operational excellence. 

Innovation

Is the biotech boom on thin ice? 
Biotech-boom-bobsled.jpg

After dizzying heights of investment during the pandemic, biotechs have observed a slump, but the future looks more promising as investors push for disruptive innovation.

International

Pharma in
Kenya
Pharma-in-Kenya-elephants.jpg

Kenya is home to a budding pharma sector, but the country is still blighted by a series of access to medicine challenges. What are these, and how can pharma help? 

 

Infographic

Future the biotech rise, fall
and rebound

This infographic explores the biotech rise and marginal fall over the past five years, tracking revenue, funding levels and drug approvals. 

GOLD 24 2022 Infographic JPEG.jpg

Never miss a GOLD update, subscribe!